Pharmacological Therapies on the 2026 PN Test Plan

One word separates the two category names, and it is the word most PN candidates never notice.

The RN plan calls it Pharmacological and Parenteral Therapies. The PN plan calls it Pharmacological Therapies. Parenteral is absent, and the category is also weighted differently.

The category name and the range NCSBN assigns it

Per NCSBN's 2026 PN test plan, Pharmacological Therapies accounts for 10 to 16 percent of the exam, with a midpoint of 13 percent. As with every category on the plan, that published band can shift by as much as three percent either way.

On the RN plan, the equivalent category is set at 13 to 19 percent. So drug content occupies a smaller share of the PN exam than of the RN exam.

Smaller is not small. At the top of the band it is close to one item in six.

What the missing word does and does not tell you

Here is where a lot of prep material overreaches, so this section will be careful.

NCSBN publishes the category names. It does not publish a rationale for why parenteral is absent from the PN label, and nothing here should be read as one. What can be said honestly is that the name is a signal about emphasis, not a rule about what will never appear.

Treat it as a weighting hint. Do not treat it as permission to skip anything your programme taught you.

The safer reading is the one that matches the rest of the PN plan. PN items lean toward recognise, monitor, report and assist rather than toward independent interpretation and adjustment. A category name that drops a route of administration from its title is consistent with that lean, and consistent is as strong a claim as the published material supports.

What that means for the shape of the questions

Expect the emphasis to land on the work around the medication rather than on the arithmetic of the order.

That means what you check before you give it. What you watch for after. What you teach the patient and family. What you report, to whom, and how urgently. Which observation means stop and ask rather than continue and chart.

Those are the decision points a coordinating role owns. They also happen to be the ones most study material treats as an afterthought, because RN-oriented rationales spend their energy on interpretation instead.

Why drug study feels bottomless, and what to do about it

Nobody finishes pharmacology. The list of drugs a stem could name is effectively unlimited and your exam is finite, so covering it is not a strategy that terminates.

What does terminate is learning behaviour by family. A drug you have never seen still belongs to a class, and a class has a predictable set of things you check, watch and report.

So an unfamiliar name in a stem stops being a dead end. It becomes a question about which family it sits in and what that family does.

That skill is worth more than another hundred flashcards. It also holds up when you are tired, which flashcards do not.

How to prioritise drug study when the category is smaller

The temptation with a smaller category is to study it less. The better move is to study it differently.

Pharmacology has the worst ratio of memorisation effort to items returned of anything on the plan, because the possible drug list is effectively bottomless and the exam is finite. So stop trying to cover it and start trying to pattern it.

Three passes work better than one long one.

• Group drugs by what you monitor, not by alphabet or by system.
• For each group, learn one parameter you check before, one you watch during, and one you report after.
• Learn the family behaviour first and the individual exceptions second.

That last one is the whole game. If you know what a class does, an unfamiliar drug name in a stem stops being a dead end.

Where a specific class list belongs is its own post, built PN first rather than trimmed down from RN material, and that is a PN first drug class list.

Monitoring parameters for the high-alert medications are also handled separately, one parameter before, during and after, in high alert medications and the parameter that matters. Neither subject is duplicated here.

The three questions that carry most of the items

Before, during, after. That is the whole frame, and it maps onto how PN pharmacology items are usually built.

Before means what you confirm exists and what you check first. The right patient and the right medication, and the one observation that would make you stop and ask rather than proceed.

During means what you are watching while it takes effect, and how soon you would expect to see anything at all.

After means what you record, what you teach, and what you report. Reporting is the verb that appears most often in correct PN rationales here, and it is not timidity. It is the coordinating role doing what it exists to do.

If you can answer those three for a drug family, you can usually answer an item about a drug in it that you have never met.

Where this category sits against the rest of the plan

Pharmacological Therapies is one of two categories whose name appears only on the PN plan. It is also one of only two categories weighted lower on the PN plan than on the RN plan.

That combination is worth holding in mind when you build a schedule. A lower weighting does not mean a lower priority if drugs are your weakest area, and a higher weighting does not mean a subject you already own deserves more hours.

The full eight-category comparison lives in one place, how the PN client needs percentages differ from the RN plan, and the category that gained the most relative weight on the PN plan is covered in why psychosocial integrity weighs more on the PN exam.

For why the PN plan is a separate instrument rather than a reduced version of the RN one, start with what makes the PN a different exam rather than a smaller one.